Novartis, which last week was publicly shamed by the FDA for manipulating data tied to the application of its gene therapy Zolgensma, has said that...
Continue ReadingGranules India Ltd’s Bonthapally facility located at Hyderabad, Telangana, India has completed the US FDA inspection from 22nd July 2019 to 26th July 2019 with...
Continue ReadingCould a manufacturing mix-up be as detrimental as the fact that a drug simply doesn’t work? Nektar learned the answer the hard way with its...
Continue ReadingDrug firm Lupin said that it has received an Establishment Inspection Report (EIR) from the US health regulator for its Aurangabad facility in Maharashtra. The...
Continue ReadingMylan N. V. and Pfizer announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new...
Continue ReadingNovartis Chief Executive Vas Narasimhan pledged in an interview not to sell the Swiss drugmaker’s generics unit Sandoz amid a revamp that has prompted speculation...
Continue ReadingNovadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval for their generic version of...
Continue ReadingKatherine Eban’s new book, “Bottle of Lies,” has focused a very intense spotlight on the mostly ignored transgressions of the Indian generic pharmaceutical industry in...
Continue ReadingSkilled manpower and improved quality of medicines and more focus on foreign markets have helped Bangladesh to expand its pharma market to 144 countries. Bangladesh’s...
Continue Reading
Plot no-118-A, Five Star Industrial Area, MIDC, Shendra, Aurangabad.
Survey No.271,Muppireddypalli (Village),Toopran Mandal, Medak District, Hyderabad,Telangana
Survey No.255, Kandlakoya Village, Medchal R R Dist, Hyderabad,Telangana
Plot No.109 to 111&115 IDA Medchal R R District, Hyderabad,Telangana
Gundlapochampally, Telangana 500014
MEDCHAL, NEAR ELECTRICAL OFFICE, 501401 R R DIST. Hyderabad
